MENU
SAGE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Sage Therapeutics (SAGE) Ownership - Who owns Sage Therapeutics?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
215 First Street
Phone
+1 617 299-8380
Employees
487
Web
https://www.sagerx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
322.38M
P/E Ratio
N/A
Total Cash
569.15M
Projected Growth
N/A
Total Debt
10.27M
Revenue
106.4M
Risk (Beta)
0.30
Dividend Yield
N/A
Total Cash/Share
9.30
Total Debt/Equity
N/A
Revenue/Share
1.76 USD as % of share price
Fundamentals
SAGE
Capitalization
322M
P/E Ratio
N/A
Risk (Beta)
0.30
Dividend Yield
N/A
Total Cash
569M
Total Cash/Share
9.30
Total Debt
10.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.76%
Revenue
106M
ROE
N/A
Book Value
552M
P/B Ratio
0.58
Cash Flow
N/A
Earnings
-5.57
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
10.02
Current Revenue Per Employee
24375.77
Dividends Per Share - Security
N/A
EBITDA
-371.15M
Float
N/A
Float - Current
N/A
Gross Income Margin
55.54
Revenue To Assets
-42.95
Shares Held By Institutions
807M
Shares Outstanding - Current
61.2M
Total Liabilities
70.6M
Total Volume MTD
N/A
Value
1
Gain YTD
-75.681
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics and medicines for central nervous system disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
215 First Street
Phone
+1 617 299-8380
Employees
487
Web
https://www.sagerx.com